Detection, identification and quantification of potential genotoxic compound in chlorhexidine drug substance

Posters | 2015 | Agilent Technologies | HPLC SymposiumInstrumentation
LC/HRMS, LC/MS, LC/MS/MS, LC/TOF
Industries
Pharma & Biopharma
Manufacturer
Agilent Technologies
Downloadable PDF for viewing
 

Similar PDF

Screening, Identifying, and Quantifying Potential Genotoxic Compounds Using High Resolution LC/MS
Screening and Identification of Potential Genotoxic Degradation Impurities using Q-TOF LC/MS with Advanced Software Solutions
Application of an Accurate Mass Database and Library for the Screening and Verification of Extractables and Leachables in Pharmaceutical Drug Products
Differential Analysis in Screening Assays for Extractable and Leachable Compounds